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The glycine and somatostatin (SS) neurotransmission 
systems in the brain have been implicated in the func- 
tion of sensory, motor, and nociceptive pathways. To 
investigate a possible relationship between these two 
components, we studied the influence of glycine on 
the binding of 1251-Tyr'1-SS to its receptors and on 
SS-like immunoreactivity (SSLI) levels in the rat hip- 
pocampus and frontoparietal cortex. An intracere- 
broventricular (i.c.v.) dose of 16 or 160 nmol of gly- 
cine induced an increase in the total number of 
specific SS receptors in the hippocampus but not in 
the frontoparietal cortex at 15 min following injec- 
tion, with no changes in the affinity constant. This 
effect seems to be mediated by inhibitory strychnine- 
sensitive glycine receptors since pretreatment with 
the antagonist strychnine (80 pg/lOO g body weight, 
intravenously) abolished this response. No significant 
changes in SSLI content were detected in either brain 
region of glycine- and strychnine plus glycine-treated 
rats as compared to control values. Since SS recep- 
tors are coupled via guanine nucleotide-binding G 
proteins to the adenylyi cyclase (AC) system, we also 
examined the inhibitory effects of SS and the guanine 
nucleotide Gpp(NH)p on AC activity in hippocampal 
membranes of control, glycine- and strychnine plus 
glycine-treated rats since the increase in SS receptors 
was observed only in this brain area. No significant 
differences were observed for the forskolin (FK)- 
stimulated AC enzyme activities in hippocampal 
membranes from all the experimental groups studied. 
In the hippocampus of the glycine- (160 nmol) treated 
group, however, basal AC activity was significantly 
lower, and the capacity of SS to inhibit FK-stimulated 
AC activity was increased as compared to the control 
group. Pretreatment with strychnine prevented the 
increase in SS-mediated inhibition of AC activity. 
The functional activity of the inhibitory guanine nu- 
cleotide-binding protein Gi, as determined by the in- 
hibitory effect of the stable GTP analogue Gpp(NH)p 
on FK-stimulated AC activity, was significantly 
higher in hippocampal membranes of glycine- (160 
nmol) treated rats as compared to controls. This sug- 
gests that the increased inhibition of AC activity by 
SS in the glycine-treated group may be due to the 
increase in Gi activity and/or the increase in the num- 
ber of SS receptors observed. Alternatively, the 
greater Gi activity may be responsible for the in- 
creased binding of 1251-Tyr11-SS to its receptors ob- 
served after glycine administration. Altogether, these 
data suggest that the hippocampal somatostatinergic 
system can be regulated by strychnine-sensitive gly- 
cine receptors in the rat. 
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INTRODUCTION 
Somatostatin (SS) and glycine are two inhibitory 
neurotransmitters in the mammalian central nervous sys- 
tem (CNS) which have been implicated in the function of 
sensory, motor, and nociceptive pathways (Epelbaum, 
1986; Betz, 1991). Until recently, glycine was generally 
not considered to play a significant role in neurotrans- 
mission above the level of the mammalian brainstem. 
Several reports, however, have suggested that glycine 
can affect neuronal activity in higher brain regions (Rai- 
teri et al., 1990; Schmidt and Taylor, 1990; Ito and 
Cherubini, 1991; Shirasaki et al., 1991). Immunocy- 
tochemical studies have shown that glycine-immunore- 
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(IBMX), ATP, GTP, Gpp[NH]p, creatine kinase, and 
creatine phosphate were all supplied by Sigma Quimica 
(Madrid, Spain). The rabbit antibody used in the radio- 
immunoassay technique was purchased from the Radio- 
chemical Centre (Amersham, U.K.). This antiserum was 
raised in rabbits against SS-14 conjugated to BSA and is 
specific for SS, but since SS-14 constitutes the C-termi- 
nal portions of both SS-25 and SS-28, the antiserum does 
not distinguish between these three forms. Cross-reac- 
tivity with other peptides was less than 0.5%. Cross- 
reaction with several SS analogues demonstrated that 
neither the N-terminal glycine nor the C-terminal cys- 
teine residue is required for antibody binding, suggesting 
that the antigen site is directed toward the central part of 
the molecule containing the tryptophan residue. The 
binding of SS-14 to this antibody does not depend on an 
intact disulfide bond in the molecule as breaking of the 
disulfide bond by reaction with 0.1 % mercaptoethanol 
(boiling water bath, 5 min) did not change the immuno- 
reactivity of the peptide. 
Experimental Animals 
The animals used in this study were 30 Wistar rats 
weighing between 200 and 250 g. Rats were maintained 
on a 12 hr light/dark cycle (0700-1900) and allowed free 
access to food. Glycine was dissolved in 0.9% NaCl and 
administered intracerebroventricularly (i.c.v.) in a vol- 
ume of 10 pl according to the method described by No- 
ble et al. (1967) at a dose of 16 or 160 nmol of free base, 
as previously described (Danysz et al., 1989). Strych- 
nine (80 pg free base/100 g body weight) was dissolved 
in saline and administered intravenously via the jugular 
vein in a volume of 100 pU100 g body weight (Brown 
and Vale, 1975) 5 min before glycine administration. In 
all experiments, control animals received equivalent vol- 
umes of the corresponding vehicle. All rats were sacri- 
ficed by decapitation 15 min after the last drug injection. 
The brain was rapidly removed, and the frontoparietal 
cortex and hippocampus were dissected over ice. 
Tissue Extraction and SS Radioimmunoassay 
For SSLI measurements, the frontoparietal cortex 
and hippocampus were rapidly homogenized in 1 m12 M 
acetic acid using a Brinkman polytron (setting 5 ,  30 sec). 
The extracts were boiled for 5 min in a water bath, 
chilled in ice, and aliquots (100 p1) were removed for 
protein determination (Patel and Reichlin, 1978). The 
homogenates were subsequently centrifuged at 15,OOOg 
for 15 min at 4"C, and the supernatant was neutralized 
with 2 M NaOH. The extracts were then stored at -70°C 
until assay. The SSLI content was determined in tissue 
extracts by a modified radioimmunoassay method (Patel 
and Reichlin, 1978), with a sensitivity limit of 10 pg/ml. 
Incubation tubes prepared in duplicate contained 1OO-pJ 
active fibers (Van den Pol and Gorcs, 1988) are present 
in the various brain regions known to contain SS-positive 
nerve terminals (Kohler and Chan-Palay, 1982; Joels et 
al., 1990). Furthermore, a dense localization of SS re- 
ceptors has been detected in the rat cerebral cortex and 
hippocampus (Srikant and Patel, 1981; Epelbaum et al., 
1982; Czernik and Petrack, 1983; Reubi and Maurer, 
1985), two brain regions which have been demonstrated 
to contain inhibitory glycine receptors (Van den Pol and 
Gorcs, 1988; Malosio et al., 1991; Naas et al., 1991; 
Becker et al., 1993; Siebler et al., 1993). Colocalization 
of SS and glycine has been characterized in amacrine 
cells of the retina (Smiley and Basinger, 1989). In addi- 
tion, both glycine (Toth et al., 1983) and SS (Higuchi et 
al., 1984; Vezzani et al., 1991) have been shown to 
possess anticonvulsant properties. In view of all this, it is 
reasonable to consider a reciprocal functional link be- 
tween the glycinergic and somatostatinergic systems. To 
date, there is no report concerning the influence of gly- 
cinergic neurotransmission on SS binding or on the abil- 
ity of SS to inhibit adenylyl cyclase (AC) activity in the 
brain. The present study was thus undertaken in order to 
analyze the action of glycine on specific SS receptor 
binding and SS-like immunoreactivity (SSLI) content in 
the rat frontoparietal cortex and hippocampus. Since SS 
modulation of neural function involves the inhibition of 
AC activity through activation of SS receptors coupled 
via GTP-binding "G" proteins to the enzyme (Schettini 
et al., 1989; Law et al., 1991), the density of the SS 
receptor binding sites was compared with SS-mediated 
inhibition of AC activity in hippocampal membranes 
from control, glycine-, and strychnine plus glycine- 
treated rats. In addition, we have measured the overall 
catalytic activity of the enzyme using forskolin (FK), an 
agent which potently stimulates the catalytic subunit 
of AC (Schettini et al., 1989). Furthermore, by using 
the stable GTP analogue 5 '-guanylylimidodiphosphate, 
[Gpp(NH)p] , we determined the functional activity of 
the Gi proteins in the control, glycine, and glycine plus 
strychnine groups. In view of the rapid onset of glycine 
action in the CNS (Betz, 1991), rats from all experimen- 
tal groups were sacrificed 15 min after the last drug 
injection. 
MATERIALS AND METHODS 
Chemicals 
Synthetic Tyr"-SS and SS-14 were purchased 
from Universal Biologicals Ltd (Cambridge, U.K.); car- 
rier-free Na'251 (IMS 30, 100 mCi/ml) and rabbit anti- 
body were purchased from the Radiochemical Centre 
(Amersham, U.K.); glycine, strychnine sulfate, bacitra- 
cin, bovine serum albumin (BSA), FK, phenylmethyl- 
sulfonyl fluoride (PMSF), 3-isobutyl- 1 -methylxanthine 
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samples of unknown or standard solutions of 0-500 pg 
cyclic SS tetradecapeptide diluted in phosphate buffer 
(0.05 M, pH 7.2 containing 0.3% BSA, 0.01 M EDTA), 
200 pl of appropriately diluted anti-SS serum, 100 pl of 
freshly prepared 1251-Tyr' -SS diluted in buffer to give 
6,000 cprdassay tube (equivalent to 5-10 pg), and 
enough buffer to give a final volume of 0.8 ml. All 
reagents, as well as the assay tubes, were kept chilled in 
ice before their incubation for 48 hr at 4°C. Separation of 
bound and free hormone was accomplished by the addi- 
tion of 1 ml dextran-coated charcoal (dextran T-70: 0.2% 
w/v, Pharmacia, Uppsala, Sweden; charcoal Norit A: 2% 
w/v, Serva, Feinbiochemica, Heidelberg, Germany). Se- 
rial dilution curves for each brain area were parallel to 
the standard curve. The intra- and interassay coefficients 
of variation were 6.2 and 8.6%, respectively. 
Binding Assay 
Tyr' '-SS was radioiodinated by Chloramine-T io- 
dination according to the method of Greenwood (Green- 
wood et al., 1963). The tracer was purified in a Sepha- 
dex G-25 fine column (1 X 100 cm) equilibrated with 
0.1 M acetic acid containing BSA 0.1 % (w/v). The spe- 
cific activity of the purified labeled peptide was about 
600 Ci/g. 
Hippocampal and frontoparietal cortex membranes 
were prepared as previously described by Reubi et al. 
(198 1). Protein concentration was assayed by the method 
of Lowry (Lowry et al., 1951), with BSA as a standard. 
Specific SS binding was measured according to the mod- 
ified method of Czernik and Petrack (1983). Briefly, the 
membranes (0.15 mg protein/ml) were incubated in 250 
pl of a medium containing 50 mM Tris-HC1 buffer (pH 
7 3 ,  5 mM MgCl,, 0.2% (w/v) BSA, and 0.1 mg/ml 
bacitracin with 250 pM '251-Tyr"-SS either in the ab- 
sence or presence of 0.01-10 nM unlabeled SS. After a 
60-min incubation at 30"C, bound and free ligand were 
separated by centrifugation at 11,OOOg for 2 min, and the 
radioactivity in the resultant pellet was measured. Non- 
specific binding was obtained from the amount of radio- 
activity bound in the presence of M SS and repre- 
sented about 20% of the binding observed in the absence 
of unlabeled peptide. This non-specific component was 
subtracted from the total bound radioactivity in order to 
obtain the corresponding specific binding. 
Evaluation of Radiolabeled Peptide Degradation 
The inactivation of '251-Tyr'1-SS in the incubation 
medium after exposure to membranes was studied by 
measuring the ability of preincubated peptide to rebind to 
fresh membranes. Briefly, '251-Tyr"-SS (250 pM) was 
incubated with membranes from rat hippocampus and 
frontoparietal cortex (0.15 mg proteidml) for 60 min at 
30°C. After this preincubation, aliquots of the medium 
were added to fresh membranes and incubated for an 
additional 60 min at 30°C. The fraction of the added 
radiolabeled peptide which was specifically bound dur- 
ing the second incubation was measured and expressed 
as a percentage of the binding that had been obtained in 
control experiments performed in the absence of mem- 
branes during the preincubation period. 
Adenylyl Cyclase Assay 
AC activity was measured as previously reported 
(Houslay et al., 1976) with minor modifications. 
Briefly, hippocampal and frontoparietal cortex mem- 
branes (0.06 mg/ml) were incubated with 1.5 mM ATP, 
5 mM MgSO,, 10 pM GTP, an ATP-regenerating sys- 
tem (7.5 mg/ml creatin phosphate and 1 mg/ml creatine 
kinase), 1 mM IBMX, 0.1 mM PMSF, 1 mg/ml baci- 
tracin, 1 mM EDTA, and test substances ( lop4 M SS or 
lop5 M FK) in 0.1 ml of 0.025 M triethanolamine/HCl 
buffer (pH 7.4). After a 15-min incubation at 30"C, the 
reaction was stopped by heating the mixture for 3 min. 
After cooling, 0.2 ml of an alumina slurry (0.75 g/ml in 
triethanolamine/HCl buffer, pH 7.4) was added, and the 
suspension was centrifuged. The supernatant was taken 
for assay of cyclic AMP (CAMP) by the method of Gil- 
man (1970). The SS concentration used was that neces- 
s a r y  to achieve inhibition of rat (Schettini et al., 1989) 
and human (Bergstrom et al., 1991) brain AC activity. 
FK was used at a concentration that could effectively 
stimulate the catalytic subunit of rat AC (Schettini et al., 
1989). 
Data Analysis 
The computer program LIGAND (Munson and 
Rodbard, 1980) was used to analyze the binding data. 
The use of this program enabled models of receptors that 
best fit the given sets of data to be selected. The same 
program was also used to present the data in the form of 
Scatchard plots and to compute values for receptor af- 
finity (Kd) and density (BmJ that best fit the sets of 
binding data for each rat. Statistical comparisons of all 
the data were carried out with one-way analysis of vari- 
ance (ANOVA) and the Student Newman-Keuls test. 
Means among groups were considered significantly dif- 
ferent when the P value was less than .05. Each individ- 
ual experiment was performed in duplicate. 
RESULTS 
Glycine administration at a dose of 16 or 160 nmol 
increased the specific binding of SS to rat hippocampal 
membranes 15 min after its i.c.v. injection as compared 
to control conditions (Table I; Fig. 1). When comparing 
the corresponding curves of 1251-Tyr' '-SS displacement 
by increasing concentrations of the unlabeled neuropep- 
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TABLE I. Effect of Glycine (16 nmol or 160 nmolirat) and Strychnine (80 pg/lOO g Body 
Weight) Plus Glycine (160 nmol/rat) on Equilibrium Parameters for Somatostatin (SS) Binding 
to Rat Frontoparietal Cortex and Hippocampal Membranest 
SS receptors 
Hippocampus 
Groups Bmax K* 
Control 391 f 12 0.35 ? 0.04 
Glycine 16 nmol 460 f 21* 0.35 f 0.02 
Control 391 f 26 0.39 k 0.04 
Glycine 160 nmol 521 t 29* 0.42 k 0.04 
Control 410 f 24 0.41 I?r 0.08 
Strychnine (80 pg) plus glycine (160 nmol) 0.38 * 0.06 386 f 29 
FrontODaneta1 cortex 
Bmax Kd 
449 2 30 0.51 t 0.02 
442 t 34 0.44 k 0.05 
390 f 63 0.45 f 0.05 
440 t 56 0.49 t 0.05 
427 k 31 0.46 t 0.08 
404 k 32 0.52 f 0.07 
'Binding parameters were calculated from Scatchard plots by linear regression. Units for K, are nM and 
units for B,, are femtomoles of SS bound per mg of protein. The results are represented as the mean f 
SEM of five separate experiments, each performed in duplicate. Statistical comparison versus control: 
*P < .05. 
tide, the binding data were significantly higher in the 
glycine-treated rats throughout the whole range studied 
(Fig. 1, left panel). Scatchard plots of the stoichiometric 
binding data were linear and essentially parallel (Fig. 1, 
right panel). Interpretation of these data with the 
LIGAND computer program resulted in the best fit for a 
model with one type of SS receptor. Hippocampal mem- 
branes from glycine-treated rats exhibited a significant 
increase in the maximum SS-binding capacity at both 
doses studied (Table I; Fig. 1). The corresponding K, 
values, however, remained unchanged after glycine ad- 
ministration. No changes in either the number or affinity 
of SS receptors were detected in frontoparietal cortex 
membranes of rats treated with 16 or 160 nmol of glycine 
(Table I). 
To assess whether glycine exerts a direct action on 
SS receptors, glycine ( lop5 M) was included in the in- 
cubation medium at the time of the binding assay with 
hippocampal membranes from normal rats. The addition 
of glycine had no effect on the SS receptors from this 
brain area (data not shown). 
Hippocampal or frontoparietal cortex membranes 
from each experimental group showed a similar peptide 
degradation capacity, and the values varied by no more 
than 10% among the experimental groups. 
Since the rise in the number of SS receptors was 
observed only in the hippocampus and the effect was 
greater in rats treated with 160 nmol (33.2% increase) 
than in those treated with 16 nmol (17.6% increase), the 
functional coupling of SS receptors to the AC system 
was studied in hippocampal membranes from control rats 
and rats treated with 160 nmol of glycine. The effect of 
SS on basal and FK-stimulated AC activity was mark- 
edly increased in hippocampal membranes from glycine 
(160 nmo1)-treated rats as compared to control animals 
(Table 11; Fig. 2). Basal AC activity was significantly 
decreased in rats treated with 160 nmol of glycine as 
0.12 
W 
0.00 
m 11 10 9 8 0.00 0.04 0.08 
Bound, nM [ S S ] ,  -log M 
Fig. 1. Effect of 160 nmol glycine, administered intracere- 
broventricularly , on somatostatin (SS) binding to rat hippo- 
carnpal membranes at 15 min after drug injection. Left panel: 
Competitive inhibition of specific 1251-Tyr1 I-SS binding by un- 
labeled SS to hippocampal membranes. Membranes (0.15 mg 
proteiniml) were incubated for 60 min at 30°C in the presence 
of 250 pM '251-Tyr'1-SS and increasing concentrations of na- 
tive peptide. Points correspond to values for the control rats 
(0, n = 5 )  and rats treated with 160 nmol of glycine (0, n = 
5) .  Each point represents the mean +- SEM of five separate 
experiments, each performed in duplicate. Right panel: Scat- 
chard analysis of the binding data. 
compared to control values (Table 11; Fig. 2). To test if 
the observed changes were related to modifications in the 
expression of AC, we measured the response of the 
enzyme to the diterpene FK, which is assumed to act 
directly upon the catalytic subunit. No significant differ- 
ences were detected for FK-stimulated AC activity be- 
tween the control and glycine-treated groups (Table 11). 
Further experiments explored the effect of glycine 
on the functional activity of Gi proteins in rat hippocam- 
pal membranes by determining the ability of Gpp(NH)p 
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TABLE 11. Effect of Somatostatin (SS) 
Adenylyl Cyclase Activity (pmol cAMPlminlmg Protein) in Hippocampal Membranes From 
Control Rats (n = 10) and Rats Treated With Glycine (160 nmol) (n = 5) or Strychnine 
(80 pgll00 g Body Weight) plus Glycine (160 nmol) (n = 5)' 
M) and Forskolin (FK) (10W5 M) on Brain 
Glycine Strychnine + glycine 
Control Treated Control Treated 
253 f 17 Basal activity 245 ? 1 1  188 f 11* *  242 t 13 
+ 1 0 - 4 ~  ss 169 t 12 104 * 5** 176 t 15 177 ? 15 
% SS inhibition of basal activity 31 2 4  45 ? 2* 27 ? 3 30 t 3 
+ 10-5 M FK 868 ? 44 818 t 20 852 t 30 871 t 51 
Fold FK stimulation over basal 3.5 t 0.3 4.3 t 0.3 3.5 * 0.2 3.2 f 0.1 
629 t 42 + M FK + lop4 M SS 605 ? 50 422 t 24* 
% SS inhibition of FK stimulation 30 f 4 48 * 3** 29 ? 3 2x t 2 
584 t 36 
'Values represent the mean -+ SEM of five separate experiments, each performed in duplicate. Statistical 
comparison versus control: *I' < .05, **P < .01. 
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Fig. 2. Comparison of the ability of somatostatin (SS) to in- 
hibit adenylyl cyclase (AC) activity in hippocampal mem- 
branes from control rats (n = 5) and rats treated with an 
intracerebroventricular dose of 160 nmol of glycine at 15 min 
after injection. Membrane preparations were incubated with or 
without SS ( lop4 M) in the absence (basal) or presence of lop5 
M forskolin (FK). Data are expressed as the mean 2 SEM of 
five separate experiments, each performed in duplicate. Statis- 
tical analysis was performed by ANOVA. AAA P < .001: 
comparison between basal and FK-stimulated groups. ***P < 
.001: comparison between basal and SS-treated groups. 0 P < 
.05, 0.0 P < .001: comparison between FK and FK + SS 
groups. 
to inhibit FK (3 X lop6 M)-stimulated AC activity, an 
effect that has been used by other investigators as a mea- 
sure of G, function in membranes prepared from different 
tissues (Young et al., 198 1). Hippocampal membranes 
derived from control rats yielded a characteristic biphasic 
response curve, as shown in Figure 3, which is assumed 
to be the result of G, protein activation at lower concen- 
trations of Gpp(NH)p followed by G, protein activation 
at higher concentrations. Gpp(NH)p decreased FK-stim- 
ulated AC activity with a maximum inhibition observed 
at M in control animals. The inhibitory effect of 
Gpp(NH)p on FK-stimulated AC activity was markedly 
increased in hippocampal membranes from glycine- 
treated rats (Fig. 3). 
Pretreatment with strychnine, a selective and com- 
petitive antagonist of glycine receptors, prevented the 
changes in SS receptors (Table I; Fig. 4), SS-mediated 
inhibition of AC activity (Table II), and Gi function (Fig. 
3 )  induced by glycine in hippocampal membranes. 
SSLI content in the frontoparietal cortex or hippo- 
campus was unaffected by glycine administration or by 
pretreatment with strychnine (Table 111). 
DISCUSSION 
This study demonstrates for the first time that the 
i.c.v. administration of glycine induces an increase in the 
number of SS receptors, an increase in the functional 
activity of G, proteins, and a greater SS-mediated inhi- 
bition of AC activity, with no changes in SSLI content, 
in the hippocampus but not the frontoparietal cortex of 
the rat. The present data suggest that hippocampal SS 
receptors may be modulated by glycine in vivo. This 
regulation may reflect a positive feedback mechanism 
further enhancing the modulatory effects of glycine on 
SS neurotransmission. 
The SSLI content and the equilibrium parameters 
of the SS receptors in the hippocampus and frontoparietal 
cortex of control rats were similar to those previously 
reported by others (Epelbaum et al., 1982; Pitkanen et 
al., 1986). Although the Scatchard plots of the stoichi- 
ometric data appear to be linear, this is no proof for 
receptor homogeneity. Indeed, it has been demonstrated 
for many years that SS binding in rat brain is heteroge- 
neous (Reubi, 1984). It has recently been demonstrated 
that there are five cloned SS receptors which appear to be 
expressed in the brain (Bruno et al., 1993) and which all 
have similar high affinity for SS (Bell and Reisine, 
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Fig. 3 .  Dose-effect curves for 5'-guanylylimidodiphosphate 
[Gpp(NH)p]-mediated inhibition of adenylyl cyclase (AC) ac- 
tivity in rat hippocampal membranes from control (0; n = 5 
in each group), glycine-treated (160 nmol, i.c.v.) (0, n = S), 
and strychnine (80 pg/lOO g body weight, i.v.) plus glycine 
(160 nmol, i.c.v.) -treated rats (A, n = S).The effect of 
Gpp(NH)p on AC activity was studied in the presence of 3 X 
M forskolin (FK) and the indicated concentrations of 
Gpp(NH)p. Data are expressed as a percentage of FK-stimu- 
lated AC activity in the absence of Gpp(NH)p (100%). The 
results are given as the mean ? SEM of five separate deter- 
minations, each performed in duplicate. Statistical comparison 
versus control: *P < .05; ***P < .001. 
1993). Thus, a linear Scatchard plot indicates only that 
the labeled sites have similar affinity for the radioligand 
used. 
A relatively high concentration of SS ( lop4 M) was 
required to produce inhibition of AC activity. This same 
SS concentration was used by Schettini et al. (1989) and 
Bergstrom et al. (1991) in their studies on SS-mediated 
inhibition of AC activity in the rat and human brain. This 
concentration is three log units higher than that necessary 
to displace '251-Tyr"-SS binding. A possible explana- 
tion for this discrepancy may lie in the observation that G 
proteins can modulate the affinity of SS receptors and/or 
the coupling to the effector system (AC among others). 
In this respect, Enjalbert et al. (1983) demonstrated that 
the mobilization of the G protein by GTP reduces the SS 
receptor affinity for the neuropeptide in cerebral cortical 
cells. Indeed, in the presence of GTP necessary to couple 
the SS receptor to the AC catalytic subunit, the SS re- 
ceptor may shift from an apparent high-affinity state (ob- 
served in binding studies) to an apparent low-affinity 
state (observed in AC studies). 
Although it is early to speculate on the molecular 
mechanism of the glycine-mediated increase in the num- 
ber of SS receptors, the glycine receptors seem to medi- 
ate the action of this neurotransmitter since the changes 
induced by glycine on the SS receptodeffector system 
m 11 10 9 8 
[SS], -log M 
u 
0.00 0.04 0.0 
Bound, nM 
Fig. 4. Effect of pretreatment with strychnine (80 pg/100 g 
body weight, i.v.) administered 5 min before glycine (160 
nmol, i.c.v.) on somatostatin (SS) binding to rat hippocampal 
membranes at 15 min after the last drug injection. Left panel: 
Competitive inhibition of specific 1251-Tyr"-SS binding by un- 
labeled SS to hippocampal membranes. Membranes (0. 15 mg 
protein/ml) were incubated for 60 min at 30°C in the presence 
of 250 pM 1251-Tyr'1-SS and increasing concentrations of na- 
tive peptide. Points correspond to values for the control rats 
(0, n = 5 )  and rats treated with strychnine plus glycine (0, 
n = 5). Each point represents the mean * SEM of five sep- 
arate experiments, each performed in duplicate. Right panel: 
Scatchard analysis of the binding data. 
TABLE 111. Effect of Glycine (16 nmol or 160 nmol/Rat) and 
Strychnine (80 pg/lOO g Body Weight) Plus Glycine 
(160 nmol/Rat) on Somatostatin-Like Immunoreactivity (SSLI) 
Concentration in the Rat Frontoparietal Cortex 
and Hippocampus* 
Groups 
SSLI (ng/mg protein) 
Hippocampus Frontoparietal cortex 
Control 11.72 2 1.79 10.41 2 1.66 
9.48 k 2.12 9.90 2 1.81 Glycine 16 nmol 
Control 13.21 2 0.74 10.26 2 1.37 
10.21 * 2.02 13.68 2 1.28 Glycine 160 nmol 
Control 12.17 2 0.48 15.62 2 2.29 
Strychnine (80 pg) 
plus glycine (160 nmol) 15.99 2 1.87 16.50 * 2.66 
*The results are represented as the mean 2 SEM of five separate 
experiments, each performed in duplicate. 
were effectively antagonized by pretreatment with the 
alkaloid strychnine. In addition, the increase in tracer 
binding was not due to a direct effect of glycine on SS 
receptors since no change in '251-Tyr'L-SS binding was 
detected following incubation of fresh hippocampal 
membranes with glycine. The interaction of glycine with 
its receptor causes neuronal hyperpolarization by gating 
an ion channel selective for chloride, an effect which is 
specifically blocked by strychnine (Curtis et al., 1968). 
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It is possible that hyperpolarization mediated by chloride 
channels coupled to glycine receptors is an important 
factor in the action of glycine on the SS receptorieffector 
system. At present, there is evidence supporting the hy- 
pothesis that changes in membrane polarization may in- 
duce modifications in the number of receptors present in 
that membrane (Liles and Nathanson, 1987). 
The question arises as to whether the effect of gly- 
cine on the '251-Tyr"-SS receptors is a result of a direct 
interaction of the glycinergic system on the somatostatin- 
ergic system or if it is mediated through interactions 
between SS and other neurotransmitters whose release 
can be modified by glycine. Several reports of strych- 
nine-sensitive, glycine-induced norepinephrine and ace- 
tylcholine release from rat hippocampus have appeared 
(Raiteri et al., 1990; Schmidt and Taylor, 1990). The site 
at which glycine acts to produce norepinephrine or ace- 
tylcholine release in the hippocampus is pharmacologi- 
cally similar to the glycine receptor of the mammalian 
spinal cord and is not related to the glycine site associ- 
ated with the NMDA subtype of glutamate receptors 
(Schmidt and Taylor, 1990). Since the observed changes 
in SS binding are detected in an area rich in noradrener- 
gic and cholinergic innervation (Delfs et al., 1984; Mil- 
ner and Bacon, 1989), it can be speculated that the acute 
effects of glycine treatment on SS receptor binding in the 
hippocampus may be a result of SS-noradrenaline and/or 
SS-acetylcholine interactions. In this regard, our group 
of investigation has previously demonstrated that both 
the al-adrenergic and the cholinergic nicotinic systems 
induce an increase in the number of SS receptors in the 
rat hippocampus (Barrios et al., 1990; L6pez-Safiudo 
and Arilla, 1994). 
The lack of effect of glycine on SS receptors in the 
frontoparietal cortex indicates the existence of regional 
differences in the interactions between glycine and SS. 
This difference could possibly be due to regional differ- 
ences in the density of the glycine receptors. Variants of 
the a subunit which forms part of the glycine receptor- 
al, a2, and &,-have recently been identified by cDNA 
cloning in rodent and human CNS (Kuhse et al., 1990). 
In situ hybridization studies have demonstrated regional 
differences in the expression of these different glycine 
receptor a subunits (Malosio et al., 1991). The expres- 
sion of a2 mRNA was detected in the dentate gyms and 
CA2, CA3, and CA4 regions of the rat hippocampus at 
moderate levels, whereas in the cerebral cortex, a,-pos- 
itive cells appeared to be largely confined to the deeper 
layer of lamina VI. Furthermore, expression of a3 
mRNA was consistently observed throughout the hippo- 
campal formation, whereas only the infralimbic cortex 
contained a3 transcripts. As the a3 subunit forms strych- 
nine-sensitive chloride channels upon expression in Xe- 
nopus oocytes, it has been considered a ligand-binding 
subunit of a strychnine-sensitive adult-type glycine re- 
ceptor (Kuhse et al., 1990). 
Since cerebral SS receptors are coupled via inhib- 
itory Gi proteins to different cellular effector systems 
(Law et al., 1991), an analysis of Gi protein function was 
carried out by activating Gi proteins directly with low 
concentrations of the stable GTP analogue Gpp(NH)p. 
Glycine administration at a dose of 160 nmol induced an 
increase in functional Gi activity as compared to control 
values. G proteins contain three subunits (a, p, y) which 
undergo dissociation when activated (Gilman, 1987). 
Several studies have demonstrated that hormone-sensi- 
tive G proteins are regulated by C1- ions (Sternweis et 
al., 1986; Higashijima, 1992). C1- ions have been 
shown to potentiate dissociation of the Gi protein into a 
and Py subunits (Sternweis et al., 1986). Since glycine 
activates a selective C1- ion channel through interaction 
with its receptors, such a regulatory effect of C1- ions 
may explain the increase in Gi protein functionality ob- 
served in the present study. Go proteins have also been 
shown to be regulated by C1- (Higashijima et al., 1987). 
Since SS receptors are coupled to the inhibition of Ca2+ 
channels apparently through interaction with a G, protein 
and SS binding has been demonstrated to be dependent 
on the extracellular Ca2+ concentration (Susini et al., 
1985), it is tempting to speculate that the increase of SS 
receptors in glycine-treated rats may be related to 
changes in CaZ4 concentration resulting from the acti- 
vation of Go. 
Glycine administration decreased basal AC activity 
as compared to control values. The increase in Gi func- 
tion induced by glycine administration may be responsi- 
ble for this effect. The FK-stimulated AC activity, how- 
ever, was similar in hippocampal membranes of control 
and glycine-treated rats, indicating that the catalytic sub- 
unit of AC is intact. The capacity of lop4 M SS to inhibit 
basal and FK-stimulated AC activity is significantly 
greater in rats treated with 160 nmol of glycine than in 
the control animals. This increased sensitivity of AC to 
SS caused by glycine administration may be a conse- 
quence of the rise in the number of SS receptors ob- 
served. Alternatively, the increase in Gi functional ac- 
tivity may participate in the increased SS-mediated 
inhibition of the enzyme, although it is highly probable 
that a combination of both factors is involved. 
The functional significance of the present results is 
unknown. Immunohistochemically , glycine receptors 
have been preferentially localized to the apical dendrites 
of pyramidal neurons in layers I11 and V of the hippo- 
campus (Van den Pol and Gorcs, 1988). In this same 
brain area, immunohistochemical studies have revealed 
many SS-containing interneurons (Kohler and Chan-Pa- 
lay, 1982; Joels et al., 1990) and a profuse network of 
intrinsic and extrinsic SS-containing fibers which appear 
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Ito S,  Cerubini E (1991): Strychnine-sensitive glycine responses of 
neonatal rat hippocampal neurones. J Physiol (Lond) 440:67- 
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Somatostatin immunohistochemistry of hippocampal slices 
with Lucifer yellow-stained pyramidal neurons responding to 
somatostatin. Regul Pept 28:215-221. 
Kohler C, Chan-Palay V (1982): Somatostatin-like immunoreactive 
neurons in the hippocampus: an immunocytochemical study in 
the rat. Neurosci Lett 34:259-264. 
Kuhse J ,  Schmieden V, Betz H (1990): Identification and functional 
expression of a novel ligand binding subunit of the inhibitory 
glycine receptor. J Biol Chem 265:223 17-22320. 
Law S,  Manning D, Reisine T (1991): Identification of the subunits of 
GTP-binding proteins coupled to somatostatin receptors. J Biol 
Chem 266:17885-17897. 
Liles WC, Nathanson NM (1987): Regulation of muscarinic acetyl- 
choline receptor number in cultured neuronal cells by chronic 
membrane depolarization. J Neurosci 7:2556-2563. 
L6pez-Saiiudo S,  Arilla E (1994): Changes in a,-adrenergic neuro- 
transmission alter the number of somatostatin receptors in the 
rat hippocampus. Neurosci Lett 177:107-110. 
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein 
measurement with Folin phenol reagent. J Biol Chem 193:265- 
275. 
Malosio ML, Marqueze-Pouey B, Kuhse J, Betz H (1991): Wide- 
spread expression of glycine receptor subunit mRNAs in the 
adult and developing rat brain. EMBO J 10:2401-2409. 
Milner TA, Bacon CE (1989): Ultrastructural localization of tyrosine 
hydroxylase-like immunoreactivity in the rat hippocampal for- 
mation. J Comp Neurol 281:479-495. 
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approach for characterization of ligand binding systems. Anal 
Biochem 107:220-239. 
Naas E, Zilles K ,  Gnahn H, Betz H, Becker CM, Schroder H (1991): 
to project to pyramidal and granule neurons (Joels et al., 
1990). In addition, SS receptors have also been de- 
scribed in pyramidal and granule neurons (Palacios et 
al., 1986). It is well established that SS (Watson and 
Pittman, 1988; Schweitzer et al., 1993) and glycine (Ito 
and Cherubini, 1991; Shirasaki et al., 1991) inhibit hip- 
pocampal CAI pyramidal neurons. In addition, the an- 
ticonvulsant effect of SS and glycine has been demon- 
strated electophysiologically in the hippocampus (Toth et 
al., 1983; Higuchi et al., 1984; Pitkanen et al., 1986; 
Vezzani et al., 1991). Because of these overlapping bi- 
ological effects, the present results suggest that there 
may be interactions at multiple levels which allow these 
neurotransmitters to affect and augment the action of one 
another. 
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